

|
Atherosclerosis is a chronic inflammatory disease of the arterial wall that is characterized by a disturbed equilibrium of immune responses and lipid accumulation, leading to the development of plaques.
|
|
"Nanoburrs" are nanoparticles coated with a sticky protein that makes them cling onto artery walls while they slowly release drugs: the US researchers who are developing them hope they will one day provide an alternative to drug-releasing stents i...
|
|
A molecule designed to find, latch onto, then treat hardened arteries could offer a new way to tackle heart disease, say its inventors.
|
|
London, Jan 19 : Heart patients may soon be able to 'swallow their doctors', all thanks to researchers at MIT and Harvard Medical School who have built targeted nanoparticles that can cling to artery walls and slowly release medicine.
|
|
Main Category: Cardiovascular / Cardiology Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials Arena Pharmaceuticals, Inc.
|
|
Main Category: Cardiovascular / Cardiology Also Included In: Vascular ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 29 Dec 2009 - 1:00 PST Arena Pharmaceuticals, Inc.
|
|
Scientists have identified the trigger that leads to the arteries becoming damaged in the disease atherosclerosis, which causes heart attacks and strokes, in research published today in the journal Circulation.
|
|
A drug-eluting stent is an expandable metal alloy framework placed into narrowed coronary arteries that slowly releases a drug coating to treat atherosclerosis.
|